Background: Plants have consistently proven to be a reliable and yet not fully explored source of medicines. In light of this, there is a constant demand for new treatment regimens for cancer. Namibia has a rich diversity of plant species of over 4300 with 17 % of them being endemic to Namibia. Plants growing in Namibia's diverse climatic zones produce many secondary metabolites as part of adaptation to their environment. This article focused on the screening of such phytochemicals and their cytotoxic and anticancer properties in vitro. Two Namibian plants Diospyros chamaethamnus and Guibourtia coleosperma were randomly selected for this purpose. Materials and Methods: The plants were screened for the presence of coumarins, alkaloids, flavonoids, anthraquinones, steroids and terpenoids using thin layer chromatography. Anticancer screening was performed on a panel of three cancer cell lines, while cytotoxicity was determined using a human fibroblast cell line, both using the SRB method. Results: Alkaloids, anthraquinones, flavonoids and steroids were detected in both organic and aqueous extracts of the two plants. The organic plant extracts had a greater anti-proliferative effect on the cancer cell lines than the aqueous extracts; the D. chamaethamnus organic root extract was the most potent with an IC50 of 16.08, 29.12 and 24.67 µg/mL against TK10, UACC62 and MCF7 cells, respectively. Furthermore, cytotoxicity analysis revealed the non-toxic nature of the extracts, except for the organic root extract of D. chamaethamnus that showed significant cytotoxicity (IC50 13.03 µg/mL). Conclusion: D. chamaethamnus is a potential candidate for the development of a plant based cancer treatment. The study showed the value of random screening in drug discovery from plants for pharmacological activity that is unrelated to their ethnomedicinal uses.
This study aimed to determine the suitability of ethnomedicinal plants as a suitable option for palliative care of cancer in Namibia. To achieve this, key informant interviews were conducted in central and northern parts of Namibia on the use of ethnomedicinal plant products for palliation of cancer. Information from surveys on the medicinal use of plants in Oshikoto and Zambezi regions of Namibia for ailments such as tumors were used to select plants for phytochemical analysis. Plants were collected and extracts were prepared for analysis for phytochemical detection using thin layer chromatography, anti-protease, antioxidant and phytochemical quantification of Colophospermum mopane and Shinziophyton rautanenii plants. Findings from key informant interviews revealed pain management for cancer patients was the primary form of disease management at health care facilities in contrast to an established holistic palliative care system. As a result, patients looked towards alternative treatment from ethnomedicinal plant sources in their bid to palliate cancer and seek hope. Phytochemical analysis of indigenous plants collected, revealed the presence of class compounds such as flavonoids, alkaloids, triterpenes, coumarins and anthraquinones as well as biological activities such as anti-protease, antioxidant properties. In conclusion, phytochemical properties of the six plants were consistent with their ethnomedicinal use, making them a suitable option for treatment of cancer in resource poor settings such as Namibia. Further studies are required to evaluate safety and mode of action.
Cancer is a major health problem, not only in developed countries, but also in developing countries where the number of cancer-related ailments is growing. Chemotherapy is the most commonly used treatment option but side effects associated with its use necessitates the search for alternatives. Over 80% of the population in developing countries relies on ethnomedicinal plants for primary healthcare including cancer. There are concerns about the safety and efficacy of such ethnomedicines but unfortunately, the prerequisite laboratory set up for such evaluation is usually lacking. An inexpensive, sensitive, field oriented assay would greatly facilitate and improve research into alternative anticancer plant based medicinal therapies. This study proposes to evaluate the suitability of Dugesia dorotocephala as an alternative laboratory method for antiproliferative properties of indigenous plant extracts. Brown planaria, D. dorotocephala maintained under laboratory settings were divided into three groups, each containing a minimum of three planaria. Each planaria was dissected into two using a sterile scalpel. The tail section was transferred into a 24 well plate, after measuring its length in mm. Root and bark extracts of Colophospermum mopane and Schinziophyton rautanenii were prepared at concentrations (5 and 20 µg/ml) and incubated with dissected planaria for 8 days, fresh extracts were replaced every two days and the planaria was observed for its length in addition to the development of eye spots. Planaria regeneration was observed in control wells receiving no treatment, however, a growth promoting effect was exhibited by S. rautanenii root extract in a time and concentration dependant manner at 5 µg/ml. An anti-proliferative effect was observed for S. rautanenii bark extracts and this was observed at both concentrations, with the higher extract of 20 µg/ml exhibiting more growth antiproliferative activity. The extract of C. mopane root had a cytotoxic effect at concentration 20 µg/ml, causing planaria death. The use of Planaria represents an inexpensive, quantifiable, field oriented method to evaluate the effect of indigenous plant extracts in the absence of cell culture. This method is capable of distinguishing between different treatments, extract concentrations as well as time points.
The scourge of microbial infectionsMicrobial infections are a major cause of morbidity and sometimes mortality, especially in developing countries such as Namibia. Severe poverty is the root cause of this undesirable situation as it leads to malnutrition, inadequate sanitation and consumption of unclean food and drink. This, compounded by lack of education and access to primary healthcare, results in infections by microorganisms such as viruses, bacteria, fungi and protozoa (Table 4.1).The most vulnerable to infectious diseases caused by microbial agents are children under the age of five, where 66% of deaths in this age group are a result of such diseases; 34% of all deaths are attributed to infectious diseases. This was underscored by WHO's (World Health Organization's) Regional Director for Africa, Luis Gomes Sambo, in 2011 when he said 63% of deaths on the continent were caused by microbial infections, with HIV/AIDS accounting for 38.5% of these (Anon, 2012). Thus, the most vulnerable groups are young children and individuals whose immune systems are compromised by HIV infection (Table 4.2).Community-acquired bacteraemia is a major cause of death in children at rural sub-Saharan district hospitals. A study by Berkley et al. (2005) showed that 12.8% of infants younger than 60 days had bacteraemia. Escherichia coli and group b streptococcus were the predominant infectious agents. In those older than 60 days, 5.9% were infected with Streptococcus pneumoniae, Salmonella species, Haemophilus influenzae or E. coli. In Gambia, children under five years have a 2.5% risk of
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.